Production (Stage)
GT Biopharma, Inc.
GTBP
$3.10
-$0.085-2.67%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.37M | 3.95M | 6.42M | 9.25M | 9.81M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 200.00K | 188.00K | 248.00K | 18.00K | 78.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 93.00K | 93.00K | 93.00K | -- | -- |
| Total Current Assets | 2.66M | 4.23M | 6.76M | 9.27M | 9.89M |
|
|
|||||
| Total Current Assets | 2.66M | 4.23M | 6.76M | 9.27M | 9.89M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | 27.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 2.66M | 4.23M | 6.76M | 9.27M | 9.91M |
|
|
|||||
| Total Accounts Payable | 2.38M | 3.85M | 2.61M | 1.72M | 3.21M |
| Total Accrued Expenses | 1.13M | 1.80M | 1.87M | 1.77M | 963.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | 30.00K |
| Total Finance Division Other Current Liabilities | 126.00K | 252.00K | 182.00K | 277.00K | 394.00K |
| Total Other Current Liabilities | 126.00K | 252.00K | 182.00K | 277.00K | 394.00K |
| Total Current Liabilities | 3.64M | 5.90M | 4.66M | 3.76M | 4.60M |
|
|
|||||
| Total Current Liabilities | 3.64M | 5.90M | 4.66M | 3.76M | 4.60M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 3.64M | 5.90M | 4.66M | 3.76M | 4.60M |
|
|
|||||
| Common Stock & APIC | 695.02M | 693.56M | 693.55M | 693.55M | 689.64M |
| Retained Earnings | -696.00M | -695.23M | -691.45M | -688.04M | -684.33M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -981.00K | -1.67M | 2.10M | 5.51M | 5.31M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 1.00K | 1.00K | 1.00K | 1.00K | 1.00K |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 1.00K | 1.00K | 1.00K | 1.00K | 1.00K |
|
|
|||||
| Total Common Equity | -981.00K | -1.67M | 2.10M | 5.51M | 5.31M |
| Total Preferred Equity | 1.00K | 1.00K | 1.00K | 1.00K | 1.00K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -980.00K | -1.67M | 2.10M | 5.51M | 5.31M |
|
|
|||||